# EDGAR Filing Document

**Accession Number:** 0002015955
**File Stem:** 0001213900-26-067101
**Filing Date:** 2026-6
**Character Count:** 60192
**Document Hash:** 43287df4d1935549705ca6a794971f56
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-067101.hdr.sgml**: 20260610

**ACCESSION NUMBER**: 0001213900-26-067101

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260610

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260610

**DATE AS OF CHANGE**: 20260610

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Lionheart Holdings
- **CENTRAL INDEX KEY:** 0002015955
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 981778167
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42135
- **FILM NUMBER:** 261078386

**BUSINESS ADDRESS:**
- **STREET 1:** 200 W. CYPRESS CREEK ROAD
- **STREET 2:** SUITE 500
- **CITY:** FORT LAUDERDATE
- **STATE:** FL
- **ZIP:** 33309
- **BUSINESS PHONE:** 3055733900

**MAIL ADDRESS:**
- **STREET 1:** 200 W. CYPRESS CREEK ROAD
- **STREET 2:** SUITE 500
- **CITY:** FORT LAUDERDATE
- **STATE:** FL
- **ZIP:** 33309

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): June 10, 2026**

**LIONHEART HOLDINGS**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-42135** | **98-1778167** |
| **(State or other jurisdiction<br> of incorporation)** | **(Commission File Number)** | **(IRS Employer<br> Identification No.)** |

---

**200 W Cypress Creek Road, Suite 500**

**Fort Lauderdale, Florida 33309**

**(Address of principal executive offices, including zip code)**

**Registrant's telephone number, including area code: (305) 573-3900**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant | **CUBWU** | The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share | **CUB** | The Nasdaq Stock Market LLC |
| Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | **CUBWW** | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01. Other Events.**

As previously disclosed, Lionheart Holdings (the "Company") has called an extraordinary general meeting of shareholders to be held on June 15, 2026 (the "Meeting") to approve an extension of time for the Company to complete an initial business combination through March 20, 2027 (the "Extension Proposal").

In connection with the Meeting, the deadline for holders of the Company's Class A ordinary shares, par value $0.0001 per share (the "Class A ordinary shares"), issued in the Company's IPO to submit their shares for redemption is 5:00 p.m. Eastern time on June 11, 2026.

In connection with the Meeting, the Company and Lionheart Sponsor, LLC (the "Sponsor") have determined that they intend to enter into one or more Non-Redemption Agreement and Assignment of Economic Interests, substantially in the form attached hereto as Exhibit 10.1 (the "Non-Redemption Agreements"), with one or more unaffiliated shareholders of the Company, pursuant to which such shareholders would agree not to redeem (or validly withdraw and rescind any redemption requests on) their Class A ordinary shares (the "Non-Redeemed Shares") in connection with the Meeting. In consideration for the foregoing commitment not to redeem the Non-Redeemed Shares, the Sponsor anticipates agreeing to transfer and assign, or cause to be transferred and assigned, to such shareholders Class B ordinary shares, par value $0.0001 per share, of the Company (the "Class B ordinary shares"), held by the Sponsor and other holders (at a ratio to be negotiated between the parties but currently expected to be at or around one Class B ordinary share for every five Non-Redeemed Shares) promptly following the closing of the Company's initial business combination if such shareholders do not exercise their redemption rights with respect to their Non-Redeemed Shares in connection with the Meeting and the Extension Proposal is approved and effected.

The Non-Redemption Agreements are not expected to increase the likelihood that the Extension Proposal is approved by the Company's shareholders at the Meeting but are expected to increase the amount of funds that remain in the Company's trust account following the Meeting, relative to the amount remaining in the trust account in the absence of the Non-Redemption Agreements.

NO ASSURANCES ARE MADE THAT A NON-REDEMPTION AGREEMENT OF ANY KIND WILL BE AGREED UPON OR CONSUMMATED AND THE ACTUAL TERMS OF ANY NON-REDEMPTION AGREEMENT MAY DIFFER MATERIALLY FROM THE TERMS DESCRIBED HEREIN.

The foregoing description of the form of Non-Redemption Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Non-Redemption Agreement filed hereto as Exhibit 10.1, which is incorporated herein by reference.

**Important Information and Where to Find It**

The Company has mailed to its shareholders of record as of May 15, 2026 a definitive proxy statement (the "Extension Proxy Statement") for the Meeting to approve the Extension Proposal. Shareholders may obtain a copy of the Extension Proxy Statement, without charge, by directing a request to: Lionheart Holdings, 200 W Cypress Creek Road, Suite 500, Fort Lauderdale, Florida 33309. The Extension Proxy Statement can also be obtained, without charge, at the U.S. Securities and Exchange Commission's (the "SEC") website (www.sec.gov).

The Company urges investors, shareholders and other interested persons to read the Extension Proxy Statement, as well as other documents filed with the SEC, because these documents do and will contain important information about the Company and the Extension Proposal.

In connection with any proposed business combination, the Company expects to file relevant materials with the SEC, which may include a proxy statement, registration statement, and other documents. Investors and security holders are urged to read all such documents carefully and in their entirety when they become available, because they will contain important information about the Company, any target, and any proposed transaction. When available, these documents may be obtained free of charge at the SEC's website or from the Company.

**Participants in the Solicitation**

The Company and its directors and executive officers may be considered participants in the solicitation of proxies with respect to the Extension Proposal and any potential transaction under the rules of the SEC. Information about the directors and executive officers of the Company is set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the SEC on March 25, 2026, and in the Company's Current Report on Form 8-K filed with the SEC on June 9, 2026. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with a potential transaction will be set forth in the Proxy Statement when it is filed with the SEC. These documents can be obtained free of charge from the sources indicated above.

**No Offer or Solicitation**

This Current Report on Form 8-K is for informational purposes only and shall not constitute a solicitation of a proxy, consent, or authorization with respect to the Extension Proposal, any securities or in respect of a proposed business combination. This Current Report on Form 8-K shall also not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Any offering of securities will be made only by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

**Forward-Looking Statements**

This Current Report on Form 8-K may contain "forward-looking statements" for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "predict," "potential," "seem," "seek," "future," "outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, without limitation, statements regarding the Company's intended acquisition focus and strategy, any potential business combination, the anticipated benefits and structure of any such transaction, the targeted assets and capital vehicle, the regulatory and policy environment in Venezuela, and the expected timing of any of the foregoing. In addition, any statements that refer to the Company's intent to enter into one or more Non-Redemption Agreements in connection with the Meeting and the expected terms of any Non-Redemption Agreements are forward-looking statements. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements.

Factors that may cause such differences include, among others: the risk that the approval of the shareholders of the Company of the Extension Proposal is not obtained; the inability to identify, negotiate, and consummate a business combination within the required time period; risks relating to U.S., Venezuelan, and international sanctions and the scope, continuation, or revocation of applicable governmental authorizations and licenses; geopolitical, regulatory, operational, and execution risks associated with energy assets in Venezuela; the availability of financing on acceptable terms, if at all; limitations on the Company's ability to enter into, and if consummated, access capital under, its planned equity facility, including registration effectiveness and trading-volume and share-price constraints; redemptions by public shareholders; and the other risks and uncertainties described from time to time in the Company's filings with the U.S. Securities and Exchange Commission.

Forward-looking statements speak only as of the date of this Current Report on Form 8-K and are not guarantees of future performance. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 10.1 | [Form of Non-Redemption Agreement and Assignment of Economic Interest](ea029424001ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **LIONHEART HOLDINGS** | **LIONHEART HOLDINGS** | **LIONHEART HOLDINGS** |
| Date: June 10, 2026 | By: | /s/ Paul Rapisarda | /s/ Paul Rapisarda |
|  |  | Name: | Paul Rapisarda |
|  |  | Title: | Chief Financial Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**NON-REDEMPTION AGREEMENT AND ASSIGNMENT OF ECONOMIC INTEREST**

This Non-Redemption Agreement and Assignment of Economic Interest (this "<u>Agreement</u>") is entered as of [___], 2026 by and among Lionheart Holdings, a Cayman Islands exempted company ("<u>Lionheart</u>"), Lionheart Sponsor, LLC, a Florida limited liability company (the "<u>Sponsor</u>"), and the undersigned investors (collectively, the "<u>Investor</u>").

**RECITALS**

**WHEREAS**, the Sponsor currently holds Lionheart Class B ordinary shares, par value $0.0001 per share, initially purchased in a private placement prior to Lionheart's initial public offering (the "<u>Founder Shares</u>");

**WHEREAS**, Lionheart expects to hold an extraordinary general meeting of shareholders (the "<u>Meeting</u>") for the purpose of approving, among other things, an amendment to Lionheart's Amended and Restated Memorandum and Articles of Association (the "<u>M&A</u>") to extend the date by which Lionheart must consummate an initial business combination (the "<u>Initial Business Combination</u>") by nine additional months until March 20, 2027 (the "<u>Extension</u>");

**WHEREAS**, the M&A provides that a shareholder of Lionheart may redeem its Class A ordinary shares, par value $0.0001 per share, initially sold as part of the units in Lionheart's initial public offering (whether they were purchased in Lionheart's initial public offering or thereafter in the open market) (the "<u>Public Shares</u>" and together with the Founder Shares, the "<u>Ordinary Shares</u>") in connection with the M&A amendment, on the terms set forth in the M&A ("<u>Redemption Rights</u>");

**WHEREAS**, subject to the terms and conditions of this Agreement, the Sponsor desires to transfer to Investor, and Investor desires to acquire from the Sponsor, that number of Founder Shares set forth opposite such Investor's name on <u>Exhibit A</u> (the "<u>Assigned Securities</u>"), to be transferred to Investor in connection with Lionheart's completion of its Initial Business Combination, and, prior to the transfer of the Assigned Securities to Investor, the Sponsor desires to assign the economic benefits of the Assigned Securities to Investor.

**NOW THEREFORE**, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Lionheart, Investor and the Sponsor hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Terms of Transfer</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.1. Upon the terms and subject to the conditions of this Agreement, if (a) as of 5:30 PM, New York time, on
the date of the Meeting, Investor holds the Investor Shares (as defined below), (b) Investor did not or does not exercise (or exercised
and validly rescinds) its Redemption Rights with respect to such Investor Shares in connection with the Meeting, (c) the Extension is
approved at the Meeting and Lionheart meets the continued or initial listing requirements to be listed on a national securities exchange
following the Meeting, and (d) Lionheart implements the Extension, then the Sponsor hereby agrees to assign to Investor for no additional
consideration the Assigned Securities set forth on <u>Exhibit A</u>, and the Sponsor further agrees to assign to Investor the Economic
Interest (as defined below) associated with the Assigned Securities that the Sponsor has agreed to assign to Investor. "Investor
Shares" shall mean an amount of the Public Shares presently held by Investor equal to the lesser of an aggregate amount of (i) the
number of Public Shares currently and anticipated to be held by the Investor as of the date of the Meeting, and (ii) 9.9% of the Public
Shares that are not to be redeemed, including those Public Shares subject to non-redemption agreements with other Lionheart shareholders
similar to this Agreement on or about the date of the Meeting. The Sponsor and Lionheart agree to provide Investor with the final number
of Investor Shares subject to this Agreement no later than 9:30 a.m. Eastern on the first business day following the date of the Meeting
(and in all cases a sufficient amount of time to allow the Investor to reverse any exercise of Redemption Rights with regard to any Investor
Shares).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.2. The Sponsor and Investor hereby agree that the assignment of the Assigned Securities shall be subject
to the conditions that (i) the Initial Business Combination is consummated; and (ii) Investor (or its permitted transferees (as such term
is described in that certain Letter Agreement, dated June 17, 2024, by and among Lionheart, the Sponsor and Lionheart's officers
and directors (as it exists on the date hereof, the " <u>Letter Agreement</u> ") executes the Joinder (as defined in Section
1.8).

Upon the satisfaction of the foregoing conditions, as applicable, the Sponsor shall promptly transfer (and no later than two (2) business days following the closing of the Initial Business Combination) the Assigned Securities to Investor (or its Permitted Transferees) free and clear of any liens or other encumbrances, other than pursuant to the Letter Agreement, restrictions on transfer imposed by the securities laws, and any successor or similar agreement entered into in connection with the Initial Business Combination (which shall be no less favorable or more restrictive than what is agreed to by the Sponsor). The Sponsor and Lionheart covenant and agree to facilitate such transfer to Investor (or its Permitted Transferees) in accordance with the foregoing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.3. <u>Merger or Reorganization, etc</u>. If there shall occur any reorganization, recapitalization, reclassification,
consolidation or merger involving Lionheart in which its Ordinary Shares are converted into or exchanged for securities, cash or other
property, then, following any such reorganization, recapitalization, reclassification, consolidation or merger, in lieu of ordinary shares
of Lionheart, the Sponsor shall transfer, with respect to each Founder Share to be transferred hereunder, upon the Sponsor' receipt
thereof, the kind and amount of securities, cash or other property into which such Assigned Securities converted or exchanged.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.4. <u>Forfeitures, Transfers, etc.</u> Investor shall not be subject to forfeiture, surrender, claw-back,
transfers, disposals, exchanges or earn-outs for any reason on the Assigned Securities. Investor acknowledges that, pursuant to the Amended
and Restated Limited Liability Company Agreement of the Sponsor (as it exists on the date hereof, the " <u>Sponsor LLC Agreement</u> "),
prior to, or in connection with, the Initial Business Combination, the managing member of the Sponsor has the authority to forfeit, transfer,
exchange or amend the terms of all or any portion of the Class A Units, Class B Units (or the Founder Shares or Private Placement Warrants
underlying such Units) (each as defined therein) or to enter into any other arrangements with respect to the Class A Units or Class B
Units (or such underlying securities) to facilitate the consummation of a Business Combination, including voting in favor of any amendment
to the terms of the Founder Shares or Private Placement Warrants, and that the managing member is authorized to effectuate such forfeitures,
transfers, exchanges or amendments, including arrangements relating to the relaxation or early release of restrictions, in such amounts
and pursuant to such terms as the managing member determines in his sole and absolute discretion for any reason. Sponsor acknowledges
and agrees that any such forfeitures, transfers, exchanges or amendments shall apply only to the Founder Shares other than the Assigned
Securities and the terms and conditions applicable to the Assigned Securities shall not be changed or reduced as a result of any such
forfeitures, transfers, exchanges or amendments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.5. <u>Delivery of Shares; Other Documents.</u> At the time of the transfer of Assigned Securities hereunder,
the Sponsor shall deliver the Assigned Securities to Investor by transfer of book-entry shares effected through Lionheart's register
of members and through Lionheart's transfer agent. The parties to this Agreement agree to execute, acknowledge and deliver such
further instruments and to do all such other acts, that are reasonably determined to be necessary or appropriate to carry out the purposes
and intent of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.6. <u>Assignment of Registration Rights</u>. Concurrent with the transfer of Assigned Securities to Investor
under this Agreement, the Sponsor hereby assigns all of its rights, duties and obligations to Investor with respect to the Assigned Securities
under that certain Registration Rights Agreement, dated June 17, 2024, by and among Lionheart, the Sponsor and Cantor Fitzgerald &
Co., a New York general partnership (as it exists on the date of the Agreement, the " <u>Registration Rights Agreement</u> "),
and hereby represents and confirms to Investor that, upon Investor's receipt of the Assigned Securities, (i) Investor shall be a
"Holder" under the Registration Rights Agreement and (ii) the Assigned Securities shall be "Registrable Securities"
under the Registration Rights Agreement. This Agreement constitutes the Sponsor's written notice to Lionheart of such assignment
in accordance with the Registration Rights Agreement (if required). Investor shall execute the Joinder (as defined in Section 1.8), pursuant
to which, Investor will be bound by the terms and provisions of the Registration Rights Agreement as a "Holder" thereunder
with respect to the Assigned Securities (upon acquisition thereof) as "Registrable Securities" thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.7. <u>Joinder to Letter Agreement and Registration Rights Agreement</u>. In connection with the transfer
of the Assigned Securities to Investor, Investor shall execute a joinder to the Letter Agreement and the Registration Rights Agreement
in substantially the form attached here to as <u>Exhibit B</u> (the " <u>Joinder</u> ") pursuant to which Investor shall agree
with Lionheart to be bound solely by Section 8 of the Letter Agreement solely with respect to the Assigned Securities and by the terms
and provisions of the Registration Rights Agreement as a "holder" thereunder with respect to the Assigned Securities (upon
acquisition thereof) as "Registrable Securities" thereunder. Notwithstanding anything in this Agreement or the Joinder to
the contrary, Investor shall be released with respect to the Assigned Securities from any transfer or lock-up restrictions under the Letter
Agreement or the Registrations Rights Agreement to the same extent as any other holders, including the Sponsor, is released from such
restrictions with respect to its remaining Founder Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.8. <u>Termination</u>. This Agreement and each of the obligations of the undersigned shall terminate on the
earlier of (a) Lionheart's shareholders do not approve the Extension at the Meeting, (b) the fulfillment of all obligations of parties
hereto, (c) the liquidation or dissolution of Lionheart, (d) the mutual written agreement of the parties hereto; or (e) if Investor exercises
its Redemption Rights with respect to any Investor Shares in connection with the Meeting and such Investors Shares are actually redeemed
in connection with the Meeting. Notwithstanding any provision in this Agreement to the contrary, the Sponsor' obligations to transfer
the Assigned Securities to Investor shall be conditioned on (i) the satisfaction of the conditions set forth in Section 1.2 and (ii) such
Investor Shares not being redeemed in connection with the Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Assignment of Economic Interest</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1. Upon satisfaction of the conditions set forth in Section 1.1, the Sponsor hereby assigns to Investor all
of its economic right, title and interest in and to that number of Assigned Securities set forth on <u>Exhibit A</u> (the " <u>Economic Interest</u> "), subject to adjustment as set forth in Section 2.2. The Economic Interest represents the Sponsor's rights to
receive dividends and other distributions made with respect to that number of Assigned Securities set forth on <u>Exhibit A</u> represented
by the Founder Shares held directly by the Sponsor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2. If at any time the number of outstanding Founder Shares is increased or decreased by a consolidation,
combination, split, subdivision, reclassification or other similar event, then, as of the effective date of such consolidation, combination,
split, subdivision, reclassification or similar event, the number of shares underlying the Economic Interest shall be adjusted in proportion
to such increase or decrease in outstanding Founder Shares. The foregoing shall not apply to (i) any increase or decrease in the number
of authorized Founder Shares or (ii) a reclassification of the share capital of Lionheart, in each case in connection with the closing
of the Initial Business Combination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.3. Investor acknowledges and agrees that it has no right to vote on matters of the Sponsor as a result of
the Assigned Securities or Economic Interest, or to vote with respect to any Assigned Securities, and it has no right to vote Assigned
Securities prior to transfer of any such shares to Investor pursuant to this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.4. Investor acknowledges and agrees that if it has a right pursuant to its Economic Interest to receive any
dividends or other distributions paid in Ordinary Shares or other non-cash property, the Sponsor shall transfer all of its right, title
and interest in such dividends or distributions concurrently with the transfer of the Assigned Securities to such Investor pursuant to
Section 1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.5. If the conditions to the transfer of the Founder Shares in Section 1 are not satisfied with respect to
any Founder Shares, then Investor shall automatically assign its Economic Interests in such Founder Shares back to the Sponsor, for no
consideration.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Representations and Warranties of Investor</u>. Investor
represents and warrants to, and agrees with, the Sponsor that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. <u>No Government Recommendation or Approval</u>. Investor understands that no federal or state agency
has passed upon or made any recommendation or endorsement of the offering of the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. <u>Accredited Investor</u>. Investor is an institutional "accredited investor" within the
meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as amended (the " <u>Securities Act</u> "), or
a "qualified institutional buyer" as defined in Rule 144A under the Securities Act, and acknowledges that the sale contemplated
hereby is being made in reliance, among other things, on a private placement exemption to "accredited investors" under the
Securities Act and similar exemptions under state law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3. <u>Intent</u>. Investor is acquiring the Assigned Securities solely for investment purposes, for such
Investor's own account (and/or for the account or benefit of its members or affiliates, as permitted), and not with a view to the
distribution thereof in violation of the Securities Act and Investor has no present arrangement to sell Assigned Securities to or through
any person or entity except as may be permitted hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4. <u>Restrictions on Transfer; Trust Account; Redemption Rights</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.1. Investor acknowledges and agrees that, prior to their transfer hereunder, the Assigned Securities are,
and following any transfer to Investor may continue to be, subject to the transfer restrictions as set forth in section 5 of the Letter
Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.2. Investor acknowledges and agrees that the Assigned Securities are not entitled to, and have no right,
interest or claim of any kind in or to, any monies held in the trust account into which the proceeds of Lionheart's initial public
offering were deposited (the " <u>Trust Account</u> ") or distributed as a result of any liquidation of the Trust Account.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.3. Investor agrees, solely for the benefit of and, notwithstanding anything else herein, enforceable only
by Lionheart, to waive any right that it may have to elect to have Lionheart redeem any Investor Shares and agrees not to redeem or otherwise
exercise any right to redeem the Investor Shares and to reverse and revoke any prior redemption elections made with respect to the Investor
Shares, in each case in connection with the Extension. For the avoidance of doubt, nothing in this Agreement is intended to restrict or
prohibit Investor's ability to redeem any Public Shares other than the Investor Shares, or to trade or redeem any Public Shares
(other than the Investor Shares) in its discretion and at any time or trade or redeem any Investor Shares in its discretion and at any
time after the date of the Meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4.4. Investor acknowledges and understands the Assigned Securities are being offered in a transaction not involving
a public offering in the United States within the meaning of the Securities Act and have not been registered under the Securities Act
and, if in the future Investor decides to offer, resell, pledge or otherwise transfer Assigned Securities, such Assigned Securities may
be offered, resold, pledged or otherwise transferred only (A) pursuant to an effective registration statement filed under the Securities
Act, (B) pursuant to an exemption from registration under Rule 144 promulgated under the Securities Act, if available, or (C) pursuant
to any other available exemption from the registration requirements of the Securities Act, and in each case in accordance with any applicable
securities laws of any state or any other jurisdiction. Investor agrees that, if any transfer of the Assigned Securities or any interest
therein is proposed to be made, as a condition precedent to any such transfer, Investor may be required to deliver to Lionheart an opinion
of counsel satisfactory to Lionheart that registration is not required with respect to the Assigned Securities to be transferred. Absent
registration or another available exemption from registration, Investor agrees it will not transfer the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5. <u>Sophisticated Investor</u>. Investor is sophisticated
in financial matters and able to evaluate the risks and benefits of the investment in the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.6. <u>Risk of Loss</u>. Investor is aware that an investment
in the Assigned Securities is highly speculative and subject to substantial risks. Investor is cognizant of and understands the risks
related to the acquisition of the Assigned Securities, including those restrictions described or provided for in this Agreement and the
Letter Agreement pertaining to transferability. Investor is able to bear the economic risk of its investment in the Assigned Securities
for an indefinite period of time and able to sustain a complete loss of such investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.7. <u>Independent Investigation</u>. Investor has relied upon
an independent investigation of Lionheart and has not relied upon any information or representations made by any third parties or upon
any oral or written representations or assurances, express or implied, from the Sponsor or any representatives or agents of the Sponsor,
other than as set forth in this Agreement. Investor is familiar with the business, operations and financial condition of Lionheart and
has had an opportunity to ask questions of, and receive answers from Lionheart's management concerning Lionheart and the terms
and conditions of the proposed sale of the Assigned Securities and has had full access to such other information concerning Lionheart
as Investor has requested. Investor confirms that all documents that it has requested have been made available and that Investor has
been supplied with all of the additional information concerning this investment which Investor has requested.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.8. <u>Organization and Authority</u>. If an entity, Investor
is duly organized and existing under the laws of the jurisdiction in which it was organized and it possesses all requisite power and
authority to acquire the Assigned Securities, enter into this Agreement and perform all the obligations required to be performed by Investor
hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.9. <u>Non-U.S. Investor</u>. If Investor is not a United States
person (as defined by Section 7701(a)(30) of the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder
(collectively, the " <u>Code</u> ")), Investor hereby represents that it has satisfied itself as to the full observance of
the laws of its jurisdiction in connection with any invitation to subscribe for the Assigned Securities or any use of this Agreement,
including (i) the legal requirements within its jurisdiction for the acquisition of the Assigned Securities, (ii) any foreign exchange
restrictions applicable to such acquisition, (iii) any governmental or other consents that may need to be obtained, and (iv) the income
tax and other tax consequences, if any, that may be relevant to the acquisition, holding, redemption, sale, or transfer of the Assigned
Securities. Investor's subscription and payment for and continued beneficial ownership of the Assigned Securities will not violate
any applicable securities or other laws of Investor's jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.10. <u>Authority</u>. This Agreement has been validly authorized,
executed and delivered by Investor and is a valid and binding agreement enforceable in accordance with its terms, except as such enforceability
may be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to,
or affecting generally the enforcement of, creditors' rights and remedies or by equitable principles of general application and
except as enforcement of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public
policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.11. <u>No Conflicts</u>. The execution, delivery and performance
of this Agreement and the consummation by Investor of the transactions contemplated hereby do not violate, conflict with or constitute
a default under (i) Investor's organizational documents, (ii) any agreement or instrument to which Investor is a party or (iii)
any law, statute, rule or regulation to which Investor is subject, or any order, judgment or decree to which Investor is subject, in
the case of clauses (ii) and (iii), that would reasonably be expected to prevent Investor from fulfilling its obligations under this
Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.12. <u>No Advice from Sponsor</u>. Investor has had the opportunity to review this Agreement and the transactions
contemplated by this Agreement and the form of Letter Agreement with Investor's own legal counsel and investment and tax advisors.
Except for any statements or representations of the Sponsor explicitly made in this Agreement, Investor is relying solely on such counsel
and advisors and not on any statements or representations, express or implied, of the Sponsor or any of its representatives or agents
for any reason whatsoever, including without limitation for legal, tax or investment advice, with respect to this investment, the Sponsor,
Lionheart, the Assigned Securities, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.13. <u>Reliance on Representations and Warranties</u>. Investor understands that the Assigned Securities are
being offered and sold to Investor in reliance on exemptions from the registration requirements under the Securities Act, and analogous
provisions in the laws and regulations of various states, and that the Sponsor is relying upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of Investor set forth in this Agreement in order to determine the applicability
of such provisions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.14. <u>No General Solicitation</u>. Investor is not subscribing for Assigned Securities as a result of or
subsequent to any general solicitation or general advertising, including but not limited to any advertisement, article, notice or other
communication published in any newspaper, magazine, or similar media or broadcast over television or radio or any seminar or meeting whose
attendees have been invited by any general solicitation or general advertising.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.15. <u>Brokers</u>. No broker, finder or intermediary has been paid or is entitled to a fee or commission
from or by Investor in connection with the acquisition of the Assigned Securities nor is Investor entitled to or will accept any such
fee or commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Representations and Warranties of Sponsor.</u> The Sponsor
represents and warrants to, and agrees with, the Investor that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. <u>Power and Authority</u>. The Sponsor is a limited liability
company duly formed and validly existing and in good standing as a limited liability company under the laws of Delaware and possesses
all requisite limited liability company power and authority to enter into this Agreement and to perform all of the obligations required
to be performed by the Sponsor hereunder, including the assignment, sale and transfer the Assigned Securities and the assignment of the
Economic Interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2. <u>Authority</u>. All corporate action on the part of the
Sponsor and its officers, directors and members necessary for the authorization, execution and delivery of this Agreement and the performance
of all obligations of the Sponsor required pursuant hereto has been taken. This Agreement has been duly executed and delivered by the
Sponsor and (assuming due authorization, execution and delivery by Investor) constitutes the Sponsor's legal, valid and binding
obligation, enforceable against the Sponsor in accordance with its terms, except as such enforceability may be limited by applicable
bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting generally the enforcement
of, creditors' rights and remedies or by equitable principles of general application and except as enforcement of rights to indemnity
and contribution may be limited by federal and state securities laws or principles of public policy.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3. <u>Title to Securities</u>. The Sponsor is the record and
beneficial owner of, and has good and marketable title to, the Assigned Securities and will, immediately prior to the transfer of the
Assigned Securities to Investor, be the record and beneficial owner of the Assigned Securities, in each case, free and clear of all liens,
pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies and other arrangements or restrictions
of any kind (other than transfer restrictions and other terms and conditions that apply to the Founder Shares generally and applicable
securities laws). The Assigned Securities to be transferred, when transferred to Investor as provided herein, will be free and clear
of all liens, pledges, security interests, charges, claims, encumbrances, agreements, options, voting trusts, proxies and other arrangements
or restrictions of any kind (other than transfer restrictions and other terms and conditions that apply to the Founder Shares generally,
under the Letter Agreement and applicable securities laws).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.4. <u>No Conflicts</u>. The execution, delivery and performance
of this Agreement and the consummation by the Sponsor of the transactions contemplated hereby do not violate, conflict with or constitute
a default under (i) the certificate of formation or the Sponsor LLC Agreement, (ii) any agreement or instrument to which the Sponsor
is a party or by which it is bound (including the Letter Agreement and the Sponsor LLC Agreement) or (iii) any law, statute, rule or
regulation to which the Sponsor is subject or any order, judgment or decree to which the Sponsor is subject. The Sponsor is not required
under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration
with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations under this Agreement,
including the transfer of the Assigned Securities and assignment of the Economic Interest in accordance with the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.5. <u>No General Solicitation</u>. The Sponsor has not offered the Assigned Securities by means of any general
solicitation or general advertising within the meaning of Regulation D of the Securities Act, including but not limited to any advertisement,
article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio or
any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.6. <u>Brokers</u>. No broker, finder or intermediary has been
paid or is entitled to a fee or commission from or by the Sponsor in connection with the sale of the Assigned Securities nor is the Sponsor
entitled to or will accept any such fee or commission.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.7. <u>Transfer Restrictions</u>. Until termination of this Agreement,
the Sponsor shall not transfer any of its Founder Shares representing the economic benefit of the Assigned Securities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.8. <u>Reliance on Representations and Warranties</u>. The Sponsor
understands and acknowledges that Investor is relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments
and understandings of the Sponsor set forth in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Trust Account</u>. Until the earlier of (a) the consummation
of Lionheart's initial business combination; (b) the liquidation of the Trust Account; and (c) 33 months from consummation of Lionheart's
initial public offering or such later time as the shareholders of Lionheart may approve in accordance with the M&A, Lionheart will
maintain the investment of funds held in the Trust Account in interest-bearing United States government securities within the meaning
of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in money market funds
meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment Company Act of 1940,
as amended, which invest only in direct U.S. government treasury obligations, or maintain such funds in cash in an interest-bearing demand
deposit account at a bank.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6. <u>Governing Law; Jurisdiction; Waiver of Jury Trial</u>.
This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving effect
to its principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of the
laws of another jurisdiction. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to
this Agreement and the transactions contemplated hereby. With respect to any suit, action or proceeding relating to the transactions
contemplated hereby, the undersigned irrevocably submit to the jurisdiction of the United States District Court or, if such court does
not have jurisdiction, the New York state courts located in the Borough of Manhattan, State of New York, which submission shall be exclusive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7. <u>Assignment; Entire Agreement; Amendment</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1. <u>Assignment</u>. Any assignment of this Agreement or any right, remedy, obligation or liability arising
hereunder by either the Sponsor or Investor to any person that is not an affiliate of such party shall require the prior written consent
of the other party; provided, that no such consent shall be required for any such assignment by Investor to one or more affiliates thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2. <u>Entire Agreement</u>. This Agreement sets forth the entire agreement and understanding between the
parties as to the subject matter thereof and merges and supersedes all prior discussions, agreements and understandings of any and every
nature among them relating to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3. <u>Amendment</u>. Except as expressly provided in this Agreement, neither this Agreement nor any term
hereof may be amended, waived, discharged or terminated other than by a written instrument signed by the party against whom enforcement
of any such amendment, waiver, discharge or termination is sought.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4. <u>Binding upon Successors</u>. This Agreement shall be binding upon and inure to the benefit of the parties
hereto and to their respective heirs, legal representatives, successors and permitted assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8. <u>Notices</u>. Unless otherwise provided herein, any notice
or other communication to a party hereunder shall be sufficiently given if in writing and personally delivered or sent by facsimile or
other electronic transmission with copy sent in another manner herein provided or sent by courier (which for all purposes of this Agreement
shall include Federal Express or another recognized overnight courier) or mailed to said party by certified mail, return receipt requested,
at its address provided for herein or such other address as either may designate for itself in such notice to the other. Communications
shall be deemed to have been received when delivered personally, on the scheduled arrival date when sent by next day or 2nd-day courier
service, or if sent by facsimile upon receipt of confirmation of transmittal or, if sent by mail, then three days after deposit in the
mail. If given by electronic transmission, such notice shall be deemed to be delivered (a) if by electronic mail, when directed to an
electronic mail address at which the party has provided to receive notice; and (b) if by any other form of electronic transmission, when
directed to such party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9. <u>Counterparts</u>. This Agreement may be executed in two
or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when
counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the
same counterpart. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S.
federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g.,
www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10. <u>Survival; Severability</u> 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.1. <u>Survival</u>. The representations, warranties, covenants and agreements of the parties hereto shall
survive the closing of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.2. <u>Severability</u>. In the event that any provision of this Agreement becomes or is declared by a court
of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision;
provided that no such severability shall be effective if it materially changes the economic benefit of this Agreement to any party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11. <u>Headings</u> *.* The titles and subtitles used in this
Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12. <u>Disclosure; Waiver</u>. As soon as practicable, but in
no event later than one business day, after execution of this Agreement, Lionheart will file (to the extent that it has not already filed)
a Current Report on Form 8-K under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), reporting the material
terms of this Agreement. The parties to this Agreement shall cooperate with one another to assure that such disclosure is accurate. Lionheart
agrees that the name of the investor shall not be included in any public disclosures related to this Agreement unless required by applicable
law, regulation or stock exchange rule. Investor (i) acknowledges that the Sponsor may possess or have access to material non-public
information which has not been communicated to the Investor; (ii) hereby waives any and all claims, whether at law, in equity or otherwise,
that he, she, or it may now have or may hereafter acquire, whether presently known or unknown, against the Sponsor or any of Lionheart's
officers, directors, employees, agents, affiliates, subsidiaries, successors or assigns relating to any failure to disclose any non-public
information in connection with the transaction contemplated by this Agreement, including any potential business combination involving
Lionheart, including without limitation, any claims arising under Rule 10-b(5) of the Exchange Act; and (iii) is aware that the Sponsor
is relying on the truth of the representations set forth in Section 3 of this Agreement and the foregoing acknowledgement and waiver
in this Section 12, in connection with the transactions contemplated by this Agreement. Lionheart shall, by 9:30 a.m., New York City
time, on the first business day immediately following the date of the Meeting, issue one or more press releases or file with the United
States Securities and Exchange Commission a Current Report on Form 8-K (collectively, the "Disclosure Document") disclosing,
to the extent not previously publicly disclosed, all material terms of the transactions contemplated hereby and any other material, nonpublic
information that Lionheart has provided to Investor at any time prior to the filing of the Disclosure Document. Upon the issuance of
the Disclosure Document, to Lionheart's knowledge, Investor shall not be in possession of any material, nonpublic information received
from Lionheart or any of its officers, directors or employees.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13. <u>Independent Nature of Rights and Obligations</u>. Nothing
contained herein, and no action taken by any party pursuant hereto, shall be deemed to constitute Investor and the Sponsor as, and the
Sponsor acknowledge that Investor and the Sponsor do not so constitute, a partnership, an association, a joint venture or any other kind
of entity, or create a presumption that Investor and the Sponsor are in any way acting in concert or as a group with respect to such
obligations or the transactions contemplated by this Agreement or any matters, and the Sponsor acknowledge that Investor and the Sponsor
are not acting in concert or as a group, and the Sponsor shall not assert any such claim, with respect to such obligations or the transactions
contemplated by this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;14. <u>Most Favored Nation</u>. In the event the Sponsor or Lionheart
enter one or more other non-redemption agreements before or after the execution of this Agreement in connection with the Meeting, the
Sponsor and Lionheart represent that the terms of such other agreements are not materially more favorable to such other investors thereunder
than the terms of this Agreement are in respect of the Investor. In the event that another investor is afforded any such more favorable
terms than the Investor, the Sponsor shall promptly inform the Investor of such more favorable terms in writing, and the Investors shall
have the right to elect to have such more favorable terms included herein, in which case the parties hereto shall promptly amend this
Agreement to effect the same.

**[Remainder of Page Intentionally Left Blank; Signature Pages Follow]**

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

---

| |
|:---|
| **INVESTORS:** |
| **[_____]** |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Non-Redemption Agreement]*

 

---

| |
|:---|
| **COMPANY:** |
| LIONHEART HOLDINGS |
| By: |
| Name: |
| Title: |

---

---

| |
|:---|
| **SPONSOR:** |
| LIONHEART SPONSOR, LLC |
| By: |
| Name: |
| Title: |

---

*[Signature Page to Non-Redemption Agreement]*

 

**<u>EXHIBIT A</u>**

---

| | | |
|:---|:---|:---|
| **Investor** | **Assigned Securities /<br> Economic Interest<br> Assigned from <br> Sponsor (1)** | &nbsp;&nbsp;**Number of Public<br> Shares to be Held <br> as Investor <br> Shares (1)** |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> [___]<br>Class B Ordinary Shares | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br> [___]<br>Class A Ordinary Shares |

---

(1) One Assigned Security for every five Investor Shares.

**<u>EXHIBIT B</u>**

FORM OF JOINDER TO

LETTER AGREEMENT AND

REGISTRATION RIGHTS AGREEMENT

<u> </u> , 2026

Reference is made to that certain Non-Redemption Agreement and Assignment of Economic Interest, dated as of June [•], 2026 (the "<u>Agreement</u>"), by and among [_____] ("<u>Investor</u>"), Lionheart Holdings (the "<u>Company</u>") and Lionheart Sponsor LLC (the "<u>Sponsor</u>"), pursuant to which Investor acquired securities of the Company from the Sponsor. Capitalized terms used and not otherwise defined herein shall have the meanings given to such terms in the Agreement.

By executing this joinder, Investor hereby agrees, as of the date first set forth above, that Investor (i) shall become a party to that certain Letter Agreement, dated June 17, 2024, by and among the Company, the Sponsor and the Company's officers and directors (as it exists on the date of the Agreement, the "<u>Letter Agreement</u>"), solely with respect to Section 8 of the Letter Agreement, and shall be bound by, and shall be subject to the restrictions set forth under, the terms and provisions of such section of the Letter Agreement as an Insider (as defined therein) solely with respect to its Assigned Securities, provided, however, that the Investor shall be permitted to transfer its Assigned Securities as permitted by the Letter Agreement; and (ii) shall become a party to that certain Registration Rights Agreement, dated June 17, 2024, by and among Lionheart, the Sponsor and Cantor Fitzgerald & Co., a New York general partnership (as it exists on the date of the Agreement (as it exists on the date of the Agreement, the "<u>Registration Rights Agreement</u>"), and shall be bound by the terms and provisions of the Registration Rights Agreement as a Holder (as defined therein) and entitled to the rights of a Holder under the Registration Rights Agreement and the Assigned Securities (together with any other equity security of the Company issued or issuable with respect to any such Assigned Securities by way of a share dividend or share subdivision or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization) shall be "Registrable Securities" thereunder.

This joinder may be executed in two or more counterparts, and by facsimile, all of which shall be deemed an original and all of which together shall constitute one instrument.

**[Remainder of Page Intentionally Left Blank; Signature Pages Follow]**

---

| |
|:---|
| **INVESTOR** |
| By: |
| Name: |
| Title: |

---

---

| |
|:---|
| **<u>ACKNOWLEDGED AND AGREED:</u>** |
| LIONHEART HOLDINGS |
| By: |
| Name: |
| Title: |

---